This unit of study builds on pharmacological knowledge acquired in the 2000 level pharmacology units of study with a major emphasis on gaining an understanding of neuropharmacology. The neuropharmacology of the major neurotransmitters and their role in neuropsychiatric diseases is explored together with the treatment of conditions such as Alzheimer's disease, movement disorders, stroke, depression, anxiety, epilepsy, pain and schizophrenia.
Two 1 hour lectures per week, five 1 hour tutorials, eight 2-4 hour practicals (total 24 hours)
One 2 hour theory exam, tutorial presentation, practical report, lecture quizzes and elective project (100%)
Nestler, EJ, Hyman, SE, Holtzman, DM and Malenka, RC. Molecular Neuropharmacology: A Foundations for Clinical Neuroscience, 3rd ed. McGraw Hill, 2015.
A mark of 70 or above in [(PCOL2011 or PCOL2021 or MEDS2002) or (BMED2401 and BMED2402 and BMED2405) or (ANAT2010 or ANAT2910) or (PSYC2010 or PSYC2910 or PSYC2015)]Prohibitions